Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

HILYSENS

Financiado

Cerrado

Highly sensitive and specific low cost lab on a chip system for Lyme disease dia...

Highly sensitive and specific low cost lab on a chip system for Lyme disease diagnosis The aim of HILYSENS is to develop a novel lab-on-chip diagnostic tool to improve clinical diagnostic, disease monitoring and treatment of Lyme Disease by enabling specific and sensitive detection of the human serological response... ver más

28/02/2013

APPLIED RESEARCH U...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

APPLIED RESEARCH USING OMIC SCIENCES Identificacion de marcadores moleculares y nuevas dianas terapeuticas parael desarrollo de nuevos farmacos, metodos de diagnostico y de moto...

TRL 4-5 | 2M€

Fecha límite participación Sin fecha límite de participación.

Ver 5 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-02-28 No tenemos la información de la convocatoria

0% 72% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

5 Participantes

APPLIED RESEARCH USING OMIC...

0.00€ | Lider

STAB VIDA INVESTIGACAO E SER...

N.D. | Participante

MICROLIQUID

N.D. | Participante

Proyectos interesantes

HILYSENS II

Medical Technol...

Data Science

2M€ Cerrado

DualDur

Medical Technol...

Data Science

4M€ Cerrado

ID-Lyme

Medical Technol...

Biotechnology

3M€ Cerrado

PRONTO

Medical Technol...

Data Science

150K€ Cerrado

RAPTADIAG

Medical Technol...

Data Science

3M€ Cerrado

CPP2021-008777

Medical Technol...

Data Science

573K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

APPLIED RESEARCH USING OMIC SCIENCES Identificacion de marcadores moleculares y nuevas dianas terapeuticas parael desarrollo de nuevos farmacos, metodos de diagnostico y de moto...

TRL 4-5 | 2M€

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The aim of HILYSENS is to develop a novel lab-on-chip diagnostic tool to improve clinical diagnostic, disease monitoring and treatment of Lyme Disease by enabling specific and sensitive detection of the human serological response against its causative agent Borrelia burgdoferi infections. Lyme Disease is the most common tick-borne infection in Europe with around 85,000 new cases per year and its incidence is increasing due to climate change. Current laboratory diagnostic methods lack sensitivity and specificity to detect early cases as well as late manifestations of the disease such as chronic or autoimmune-related infections. For this reasons, disease incidence is underestimated as many cases go mis- or undiagnosed. Late, delayed, or inadequate treatment can lead to serious symptoms such as neuroborreliosis or arthritis, which can be disabling and difficult to treat. HILYSENS will develop a specific multi-antigen assay in a lab-on-a-chip device to detect Borrelia infections. HILYSENS will provide a compact and robust lab-on-chip system, designed to work with small volumes and without the need of expert operators. This tool together with a portable reader and user-friendly software will enable more precise, accurate and reproducible testing making it possible to become the standard tool for the disease diagnosis. A novel production approach for the lab-on-a-chip will be developed which will enable to target really low mass-production costs, overcoming one of the main issues of the lab-on-a-chip technology and opening great market opportunities for the participant SMEs. Sensitive and reliable patient diagnosis provided by HILYSENS device will optimise resources available to medical practitioners, heavily reducing the current costs of the disease, increasing profitability and most importantly, patients’ quality of life.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores